Aliaxin® is a monophasic dermal filler product range containing a combination of well-defined molecular weights of hyaluronic acid to obtain different biological and mechanical effects. Key features of the Aliaxin are high tissue integration and stability, resulting in natural, but at the same time long-lasting results. It is manufactured by IBSA Farmaceutici Italia in a U.S. FDA approved site in Italy, and distributed in the UK & Ireland by HA-Derma Ltd.
ALIAXIN® is the solution for global rejuvenation, enhancing the natural beauty, providing balanced aesthetic results.
The product replenishes the natural shape, fullness and symmetry of face, restores tone, increases elasticity and maintains hydration. These are the aesthetic and therapeutic results that ALIAXIN® guarantees.
Four formulations of the ALIAXIN® product line with specific and different visco-elastic properties are the result of IBSA research. IBSA technology is able to guarantee different clinical results using a combination of hyaluronic acid with different molecular weights while acting on the cross-linking grade.
ALIAXIN® possesses a natural lifting effect, combined with biological action, stimulating the regeneration of collagen structures of the dermis.
How is it made?
The Aliaxin cross-linking process results in a ready-to-use gel without the need for additional fragmentation or manipulation, with a low cross-linking percentage (<10%) and a low content of BDDE residue (<0.1ppm). All of which makes the final product safer and easier to inject thanks to the optimisation of the viscoelastic characteristics.
Is a skin test required before treatment?
No allergy test needed
Is it temporary or permanent?
Hyaluronic acid is completely broken down within the skin over a period of months, eventually leaving no trace of the filler.
Duration of effect
This depends upon the degree of correction required, your age and lifestyle as well as the correct placement of the product by a practitioner. The manufacturer IBSA claims that Aliaxin is long-lasting and effective from 6 to 12 months and suggest that one or two treatments per year are sufficient - depending on a grade used.
What does it contain?
IBSA’s hyaluronic acid is an ultrapure grade hyaluronic acid, produced through a patented bio-fermentation process, of Streptococcus Zooepidemicus, which ranks worldwide as ‘top quality’ in terms of purity, safety and its high resistance to thermal production processes.